31/05/2021
*ABM Morning Update*
*OPTIMISM RUNS HIGH ON BACK OF RAPIDLY EBBING 2ND WAVE. ‘REMARKABLE-EXUBURENCE’ BACKED BY ABUNDANT LIQUIDITY HELP NIFTY STORM TO NEW HIGH!!!!*
Asian equities trade firm & r extending their recent rally to a 3rd wk in the hope U.S. jobs figures show the xptd revival in hiring in May & keep the global recovery on track. Mkts in the US & Britain r closed for a holiday, though their futures r still trading in Asia. Chinese blue chips were soft as a survey showed a slight slowdn in factory activity but a pick-up in the service sector. The main event of the wk will be U.S. payrolls on Friday with median forecasts at 650,000 but the outcome is uncertain following April's shockingly weak 266,000 gain. That Apr figure was close to 750,000 lower than forecasts, the largest "miss" in the history of the series. Seperately, Oil prices were firm after gaining more than 5% last wk to reach 2-yr closing highs as expectations of a rebound in global demand outweighed concerns abt more supply fm Iran once sanctions are lifted. All eyes will be on OPEC this wk as it reviews its supply agreement, & any hint of an increase in output cud pressure prices. Brent trades close to $69/bl level.
On the 1st day of the June F&O series, Nifty stormed to new heights, as a trinity of rapidly ebbing 2nd wave, announcement of unlocking in the NCR, & $6 tn fiscal stimulus in the US held up investor confidence. While on one side optimism was in the air, the RBI’s AR was at pains to pt out that while some areas of the economy were badly scarred, others such as agriculture, IT, highway infrastructure, tractor sales, railway freight, domestic trade & electricity demand have been resilient. Mkt, however, was determined to look beyond the lockdowns. It ignored RBI’s warning that there may be a bubble in the making. The benchmark Nifty index scaled a fresh record peak closed up 98 pts or 0.64%. RIL was the biggest contributor towards the indices' rally, aftr the stock clocked its sharpest intra-day gain in 2Ms & zoomed 6%. That apart, Grasim, Adani Ports, M&M, Eicher Motors, Coal India, HDFC, Kotak Bk, & IndusInd Bk were the top gainers of the day, up b/w 1-3%. Broader mkts, however, settled the day in the red on the back of profit-booking.
The GST Council meeting, held after a gap of 8M announced
a) extension of IGST exception on import of free Covid relief items till 31 Aug’21,
b) inclusion of black fungus drug Amphotericin B in the exemption category, and
c) simpler compliance measures.
On the COVID-19 front, daily cases in India has fallen by over 50% (lowest since 14 Apr’21). However, WB & TN extended their lockdowns while Delhi & Maharashtra announced plans to soon unlock in a phased manner. Further, the Ministry of Home Affairs- i) directed states/UTs to continue the ongoing Covid-19 guidelines, & ii) extended the ban on international flights till 30 Jun’21. Other highlights of the wk included rptd possible stimulus package for tourism, aviation & hospitality industries & MSMEs, though FM over the weekend made it clear that the decision to grant another fiscal stimulus will be taken only after a thorough assessment.
The govt has expanded the ECLGS scheme to help businesses hit by the 2nd wave of the Covid-19 pandemic. The scheme removes the ceiling of outstanding loans of Rs 5 bn, but keeps the government’s guarantee cover of Rs 3 tn unchanged. Borrowers will be able to avail assistance ltd to 40% or Rs 2 bn, whichever is lower.
According to IMD, Monsoon rains r likely to hit India's southern coast arnd May 31, in line with typical patterns. Nearly half of India's farmland has no irrigation & depends on annual June-Sept rains to grow crops such as rice, corn, cane, cotton & soybeans. India's weather office said last month the country was xptd to get avg monsoon rains this yr, raising expectations of higher farm output, which is central to the country's economy.
Amid the concerns regarding shortage of COVID vaccines, the Centre on Sunday said India will have nearly 12 cr doses of COVID-19 vaccines available for domestic use in June. This is a significant jump from the 7.9 cr doses that were available in May. Till now, India has administered 212 mn doses, the most aftr China & the US. However, only abt 3% of the population received both the doses.
The clinical trial of Zycov-D, the 4th Covid vaccine, is over & the final results have been submitted by manufacturer Zydus Cadila to the DCGI for a go-ahead. The vaccine can be used on children in the 12-17 yrs age bracket.
*Key Things to watch out for the wk –* The MPC's int rate decision, a host of macroeconomic data announcements, COVID-19 trends & global factors wud be the major highlights in the eq mkt this wk & their outcome wud be a major driving force going ahead.
On the macroeconomic front, i) we have GDP data for the 1st qtr, core sector data, Markit Mfg PMI & services data scheduled during the wk. ii) The MPC review meeting is also scheduled this wk wherein RBI is likely to retain the benchmark int rate at the existing levels. iii) Further the monthly auto sales nos will also start pouring in fm June 1. The nos r xptd to be soft on MoM basis, mainly because of strict lockdn across many states impacting the dealership operations i.e. sales & also after major OEM had plant closure shut-dn for most part of the month.
Earnings - We are now in the last leg of earnings season. Prominent co's including Aurobindo Pharma, ITC, Motherson Sumi, PVR, Bharat Forge, will release their qtrly earnings in the coming wk. Further the expectations of state-wise gradual unlocking due to declining COVID-19 cases r giving hopes of economic recovery & wud also be watched out for by the mkt participants.
*Results*
*Divis Labs*
Sales at Rs 1788 cr vs Rs 1390 cr YoY
EBITDA at Rs 1788 cr vs Rs 1390 cr YoY
EBITDA margin at 40.1% vs 32% YoY
Profit at Rs 502 cr vs Rs 388 cr YoY
*3M India – Decent performance*
Revenue came at Rs. 827.2 cr (11.6% QoQ, 22.9% YoY)
EBIDTA came at Rs. 102.4 cr (11.7% QoQ, 34.2% YoY)
EBITDA Margin came at 12.4% vs QoQ 12.4%, YoY 11.3%
NP came at Rs. 70.5 cr vs QoQ Rs. 59.4 Cr, YoY Rs. 60.1 Cr
*GMM Pfaudler – Strong Results - (Standalone + MAVAG for like to like comparison)*
Revenue came at Rs. 214.7 cr (6.4% QoQ, 62.9% YoY)
EBIDTA came at Rs. 57.8 cr (37.8% QoQ, 157.2% YoY)
EBITDA Margin came at 26.9% vs QoQ 20.8%, YoY 17.1%
NP came at Rs. 36.2 cr vs QoQ Rs. 23.2 cr, YoY Rs. 11.6 cr
Pfaudler was consolidated only for months of Feb & Mar. Including this the combined revenue was Rs. 471 cr, EBITDA was Rs. 75.5 cr with margin of 16.0% & PAT was Rs. 57 cr (before Minority int)
*M&M – Q4FY21 - Result is marginally below expectations*
Revenue came at Rs. 13512.4 cr (-4.9% QoQ, 47.8% YoY) vs expectation of Rs. 12795.1 cr
EBIDTA came at Rs. 1789.3 cr (-21.4% QoQ, 57.7% YoY) vs expectation of Rs. 1865.1 cr
EBITDA Margin came at 13.2% vs expectation of 14.6%, QoQ 16%, YoY 12.4%
EBIT grew 92% YoY to Rs 1485 cr
NP came at Rs. 935.1 cr vs expectation of Rs. 1094.7 cr
M&M will spend Rs 12,000 cr in the nxt 3 yrs towards launching & upgrading a range of PVs & CVs as it seeks to regain lost mkt share. The capex earmarked will fuel the co’s plan of launching 23 new products in nxt 5 yrs
*Affle India – Decent Result*
Revenue came at Rs. 141.5 cr (-6% QoQ, 76.8% YoY)
EBIDTA came at Rs. 34.2 cr (-10.9% QoQ, 69.7% YoY)
EBITDA Margin came at 24.2% vs QoQ 25.5%, YoY 25.2%
NP came at Rs. 58.5 cr vs QoQ Rs. 30.6 cr, YoY Rs. 15.3 cr (Higher PAT is on a/c of higher Other Income)
Overall, the underlying momentum of mkt is xptd to stay +ve as it looks ahead at re-opening of economy & corporate profitability in the medium term.
*Quote of the Day : “There’s ‘mounting-evidence’ that commodities are no longer China-centric. The main reason for the U.S.’s greater power in the market is Washington’s fiscal stimulus, but there are also structural factors - China no longer benefits as much from low-cost labor or from its previous indifference to environmental concerns - that make this a paradigm shift” – Goldman Sachs. China’s efforts to rein in surging commodities prices are likely to be in vain as it’s lost the ability to boss the market around, according to two of Wall Street’s biggest firms. The speed of the rebound in demand in advanced economies, particularly the U.S., means China is no longer the buyer dictating pricing, Goldman Sachs Group Inc. analysts led by Jeff Currie said with the view echoed by his equivalent at Citigroup Inc., Ed Morse*
*Focus For the Day:*
1. Key Results - Aurobindo, Honeywell Automation,
2. India Q4FY21 GDP
*Key corporate developments/policy actions:*
1. India extends ban on international flights till June-end
2. In a first, petrol price crosses Rs.100 mark in Mumbai last Fri as fuel prices hiked again
3. RBI imposes Rs10 cr penalty on HDFC Bk
4. CPP Investments to buy stake in Phoenix Mills’ Kolkata mall for Rs 560 cr
5. Adani Ports and SEZ looks to acquire Karaikal Port
6. Paytm eyes $3-bn IPO
*Fund Flow:*
FII: (+) Rs9.14bn; DII : (+) Rs.12.75bn
*Stocks to focus 😗
*Large Cap 😗 Abbott India, Bajaj Finance, Divis Lab, HDFC Bank, HCL Tech, HUL, Infosys, ICICI Lombard, , Maruti, Nestle, PI Ind, Tata Steel.
*Mid Cap 😗 AAVAS Financiers, Amber Ent, AU SFB, Dalmia Bharat, Gmm Pfaudler, GNFC, Nalco, Varun Beverages, Westlife Development.